share_log

SAB Biotherapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

SAB Biotherapeutics | 425:募資說明/企業合併公告

2021/10/13 12:59
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息